NICE recommends first new treatment ‘romosozumab’ for osteoporosis
The National Institute for Health and Care Excellence (NICE) has recommended first new treatment – ‘romosozumab’ for osteoporosis for over a decade.
Thousands of people...
This site is intended for Healthcare Professionals only.
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc
This site is intended for Healthcare Professionals only.